Form4insider filings, from the source

SEC Form 4 · accession 0001231919-26-000638

Parabilis Medicines, Inc. · PBLS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
RA Capital Healthcare Fund LP
Director · 10% Owner
RA CAPITAL MANAGEMENT, L.P.
Director · 10% Owner
Peter Kolchinsky
Director · 10% Owner
Rajeev M. Shah
Director · 10% Owner
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 6:57 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001657677

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Voting Common StockF1,F2,F3,F4Jun 11, 2026C6,556,740—A6,556,740ISee footnotes
Voting Common StockF1,F2,F3,F5Jun 11, 2026C1,187,881—A1,187,881ISee footnotes
Voting Common StockF3,F4Jun 11, 2026P19,728,353$20.00A26,285,093ISee footnotes
Voting Common StockF3,F5Jun 11, 2026P1,460,397$20.00A2,648,278ISee footnotes

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Series E Preferred StockF1,F3,F4—Jun 11, 2026C642,250D——Voting Common Stock419,0060I
Series E Preferred StockF1,F3,F5—Jun 11, 2026C160,562D——Voting Common Stock104,7510I
Series F Preferred StockF2,F3,F4—Jun 11, 2026C9,445,363D——Voting Common Stock6,137,7340I
Series F Preferred StockF2,F3,F5—Jun 11, 2026C1,666,829D——Voting Common Stock1,083,1300I

Explanation of responses

Remarks

Dr. Jake Simson, a Partner of the Adviser, serves on the Issuer's board of directors.